JP2025511270A5 - - Google Patents
Info
- Publication number
- JP2025511270A5 JP2025511270A5 JP2024558218A JP2024558218A JP2025511270A5 JP 2025511270 A5 JP2025511270 A5 JP 2025511270A5 JP 2024558218 A JP2024558218 A JP 2024558218A JP 2024558218 A JP2024558218 A JP 2024558218A JP 2025511270 A5 JP2025511270 A5 JP 2025511270A5
- Authority
- JP
- Japan
- Prior art keywords
- seq
- amino acid
- sequence
- acid sequence
- antibody
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202263325578P | 2022-03-30 | 2022-03-30 | |
| US63/325,578 | 2022-03-30 | ||
| PCT/US2023/016917 WO2023192489A2 (en) | 2022-03-30 | 2023-03-30 | Anti-adenosine receptor (a2ar) antibodies and the use thereof |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2025511270A JP2025511270A (ja) | 2025-04-15 |
| JP2025511270A5 true JP2025511270A5 (https=) | 2026-04-06 |
Family
ID=88203254
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024558218A Pending JP2025511270A (ja) | 2022-03-30 | 2023-03-30 | 抗アデノシン受容体（ａ２ｒａ）抗体及その用途 |
Country Status (5)
| Country | Link |
|---|---|
| US (1) | US20250206828A1 (https=) |
| EP (1) | EP4499702A2 (https=) |
| JP (1) | JP2025511270A (https=) |
| CN (1) | CN119343375A (https=) |
| WO (1) | WO2023192489A2 (https=) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2025257365A1 (en) | 2024-06-14 | 2025-12-18 | Institut National de la Santé et de la Recherche Médicale | Adenosine a2a antagonists for the treatment of endometriosis |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| TWI560199B (en) * | 2010-08-31 | 2016-12-01 | Sanofi Sa | Peptide or peptide complex binding to α2 integrin and methods and uses involving the same |
| JP2023540339A (ja) * | 2020-09-04 | 2023-09-22 | インパクト バイオ ユーエスエー インコーポレイテッド | 癌治療に使用するためのバイシストロン性阻害性キメラ抗原受容体（ｉＣＡＲ）／活性化キメラ抗原受容体（ａＣＡＲ）構築物 |
-
2023
- 2023-03-30 WO PCT/US2023/016917 patent/WO2023192489A2/en not_active Ceased
- 2023-03-30 JP JP2024558218A patent/JP2025511270A/ja active Pending
- 2023-03-30 EP EP23781815.8A patent/EP4499702A2/en active Pending
- 2023-03-30 CN CN202380044238.1A patent/CN119343375A/zh active Pending
- 2023-03-30 US US18/851,748 patent/US20250206828A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US12350333B2 (en) | Checkpoint regulator antagonists | |
| US12404336B2 (en) | Bispecific antagonist comprising a LAG-3 binding domain | |
| US20230340132A1 (en) | ANTI-ADENOSINE RECEPTOR (A2aR) ANTIBODIES | |
| TW202134272A (zh) | 標靶ＴＧＦ－β路徑之拮抗劑 | |
| US20250206828A1 (en) | ANTI-ADENOSINE RECEPTOR (A2aR) ANTIBODIES AND THE USE THEREOF | |
| JP2025511270A5 (https=) | ||
| US20250171542A1 (en) | Anti-programmed death-ligand 1 (pd-l1) antibodies | |
| HK40124840A (zh) | 抗腺苷受体(a2ra)抗体及其用途 | |
| WO2023192289A2 (en) | Anti-trophoblast cell surface antigen 2 (trop-2) antibodies |